Neovacs | Evaluate

August 31, 2018

After Astra’s failure lupus attention turns to Aurinia

Beleaguered Neovacs still has it all to do

June 15, 2017

Therapy focus – Lupus hopes build but data remain on the distant horizon

July 06, 2015

Interview – US placement reanimates Neovacs into lupus play

January 08, 2015

Buoyant small pharma market hides some big losers

December 24, 2014

Cyclacel and Neovacs enter the graveyard shift

October 29, 2012

Therapeutic focus – Roche and AstraZeneca take interferon approach to lupus

January 16, 2012

IPO hopefuls line up after woeful 2011

November 25, 2011

EP Vantage Interview - Neovacs seeking partners for autoimmune vaccines

July 12, 2011

Tough IPO scene continues in first half 2011